Bibliography
- Ezekowitz MD. Atrial fibrillation: the epidemic of the new millennium. Ann Intern Med 1999;131(7):537–8
- Lip GY, Kakar P, Watson T. Atrial fibrillation–the growing epidemic. Heart 2007;93(5):542–3
- Piccini JP, Whellan DJ, Berridge BR, Current challenges in the evaluation of cardiac safety during drug development: translational medicine meets the Critical Path Initiative. Am Heart J 2009;158(3):317–26
- Tamargo J, Caballero R, Delpón E. Drug-induced atrial fibrillation. Expert Opin Drug Saf 2012;11(4):615–34
- Mitcheson JS, Chen J, Lin M, A structural basis for drug-induced long QT syndrome. Proc Natl Acad Sci USA 2000;97(22):12329–33
- Voora D, Ginsburg GS. Clinical application of cardiovascular pharmacogenetics. J Am Coll Cardiol 2012;60(1):9–20
- Schwarz UI, Ritchie MD, Bradford Y, Genetic determinants of response to warfarin during initial anticoagulation. N Engl J Med 2008;358(10):999–1008
- Caraco Y, Blotnick S, Muszkat M. CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study. Clin Pharmacol Ther 2008;83(3):460–70
- Sinner MF, Ellinor PT, Meitinger T, Genome-wide association studies of atrial fibrillation: past, present, and future. Cardiovasc Res 2011;89(4):701–9
- Shuraih M, Ai T, Vatta M, A common SCN5A variant alters the responsiveness of human sodium channels to class I antiarrhythmic agents. J Cardiovasc Electrophysiol 2007;18(4):434–40
- Parvez B, Vaglio J, Rowan S, Symptomatic response to antiarrhythmic drug therapy is modulated by a common single nucleotide polymorphism in atrial fibrillation. J Am Coll Cardiol 2012; published online 20 June; doi:10.1016/j.jacc.2012.01.070
- de Vos CB, Nieuwlaat R, Crijns HJ, Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey. Eur Heart J 2008;29(5):632–9
- van der Hooft CS, Heeringa J, van Herpen G, Drug-induced atrial fibrillation. Am Coll Cardiol 2004;44(11):2117–24
- Chia BL. Digitalis-induced cardiac arrhythmias. Angiology 1981;32(9):630–8
- Wang Z, Pagé P, Nattel S. Mechanism of flecainide's antiarrhythmic action in experimental atrial fibrillation. Circ Res 1992;71(2):271–87
- Eckstein J, Maesen B, Zeemering S, Effect of flecainide on endo-epicardial dissociation and the incidence of breakthrough. Heart Rhythm 2012;9(Suppl):S189